The oxidation process was conducted in a solution containing Ca(H2PO2 2, H3PO4, or (HCOO 2Ca.
In polymerizations conducted at a solution concentration of 25% by weight gelation took place at the stoichiometric ratio [A2]/[B3]=0.886.
Metal deposition was conducted in a solution of 2 × 10-2 mol dm-3 andO3 and 5 mol dm-3 HF for 5 s.
The electrodeposition process was conducted in a solution consisting of 1.0 mM H2PdCl4 and 0.33 M H3PO4 using cyclic voltammetry from -0.24 to 1.2 V with a scan rate of 50 mV s-1.
The experimental testing was conducted using a solution with concentration of cells at 1.7 × 105 cells/ml, which was introduced into the device at 100 µl/h flow rate.
Deposition of 1 µm thickness is conducted in a solution of chromium trivalent salt and oxidizing agent fluorosilicic acid (H2SiF6) operated at a current density 350 mA cm− 2 at 25 °C and 1 min.
Destaining was conducted with a solution of 40% methanol and 10% acetic acid.
TACE was conducted using a solution of 20 50 mg doxorubicin hydrochloride in a 5 20 ml mixed solution of lipiodol and contrast agent.
The initial amplification reaction was conducted in a solution of 300 mmol/l Tris-HCL (pH 9.0); 75 mmol/l (NH4 2SO4; 10 mmol/l MgCl2; 200 μmol/l each of dATP, dCTP, dGTP, and dTTP; 0.5 μM of each primer, and 2.5 U of Taq DNA polymerase (Invitrogen).
Therefore, many studies have been conducted to find a solution to increase the lifetime of these networks.
